210 related articles for article (PubMed ID: 277749)
1. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
[TBL] [Abstract][Full Text] [Related]
2. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults.
Sartiano GP; Pfrimmer WJ; Turner AR
Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748
[TBL] [Abstract][Full Text] [Related]
3. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
Skeel RT; Costello W; Bennett JM; Oken MM; Tobin MS; Bertino JR; Marsh JC; Carbone PP
Cancer; 1980 Jan; 45(2):224-31. PubMed ID: 6985830
[TBL] [Abstract][Full Text] [Related]
5. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
6. Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.
Chard RL; Finklestein JZ; Sonley MJ; Nesbit M; McCreadie S; Weiner J; Sather H; Hammond GD
Med Pediatr Oncol; 1978; 4(3):263-73. PubMed ID: 355821
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
Uzuka Y; Liong SK; Yamagata S
Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA.
Mandelli F; Vegna ML; Avvisati G; Amadori S; Spadea A; Cacciola E; Cantore N; De Laurenzi A; De Rosa C; Fioritoni G
Ann Hematol; 1992 Apr; 64(4):166-72. PubMed ID: 1581404
[TBL] [Abstract][Full Text] [Related]
9. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
10. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED
Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
12. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
Kahn SB; Begg CB; Mazza JJ; Bennett JM; Bonner H; Glick JH
J Clin Oncol; 1984 Aug; 2(8):865-70. PubMed ID: 6379120
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
14. Therapy of acute nonlymphocytic leukemia in children: a review of 73 patients.
Amadori S; Petti MC; Pacilli L; Papa G; Mandelli F
Tumori; 1981; 67(3):209-14. PubMed ID: 7025401
[TBL] [Abstract][Full Text] [Related]
15. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
16. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
17. Adult acute leukaemia.
Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
[TBL] [Abstract][Full Text] [Related]
18. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
Rees JK; Gray RG; Swirsky D; Hayhoe FG
Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
[TBL] [Abstract][Full Text] [Related]
19. A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.
Wiernik PH; Glidewell OJ; Hoagland HC; Brunner KW; Spurr CL; Cuttner J; Silver RT; Carey RW; DelDuca V; Kung FH; Holland JF
Med Pediatr Oncol; 1979; 6(3):261-77. PubMed ID: 381887
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]